Your session is about to expire
← Back to Search
Behavioral Intervention
eSTEPS Program for Fall Prevention (eSTEPS Trial)
N/A
Recruiting
Research Sponsored by Brigham and Women's Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Age 65 or above
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 21 months
Awards & highlights
eSTEPS Trial Summary
This trial evaluates a program for fall prevention by using a machine learning algorithm, provider BPA, Care Gap and Smart Set, and an eSTEPS Patient App with exercise tools.
Who is the study for?
This trial is for individuals aged 65 or older who are at risk of falling, as determined during an annual wellness visit. They must be living in the community (not in long-term care facilities) and enrolled in certain primary care practices participating in the study.Check my eligibility
What is being tested?
The eSTEPS CDS program is being tested to see if it can help prevent falls among seniors. It uses a machine learning algorithm for fall risk screening and provides doctors with decision support tools to create personalized exercise plans, which patients can follow using an app.See study design
What are the potential side effects?
Since this intervention involves exercise recommendations and digital tools rather than medication, typical drug side effects are not expected. However, participants may experience discomfort or injury related to new physical activities.
eSTEPS Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 65 years old or older.
eSTEPS Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 21 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 21 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
To determine the effect of the eSTEPS intervention on the rate of falls
Secondary outcome measures
To determine the effect of the eSTEPS intervention on falls self-efficacy (fear of falling)
To determine the effect of the eSTEPS intervention on self-efficacy for exercise
Other outcome measures
To determine the effect of the eSTEPS intervention the rate of fall injuries
To explore the effect of the eSTEPS intervention on the rate of death
eSTEPS Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: eSTEPS Clinical Decision SupportExperimental Treatment1 Intervention
Use of clinical decision support to assist in exercise-related fall prevention care planning will be compared to usual care.
Group II: Usual CareActive Control1 Intervention
Usual primary care practices regarding exercise-related fall prevention planning
Find a Location
Who is running the clinical trial?
National Institutes of Health (NIH)NIH
2,726 Previous Clinical Trials
7,487,557 Total Patients Enrolled
National Institute on Aging (NIA)NIH
1,700 Previous Clinical Trials
28,024,474 Total Patients Enrolled
Essentia HealthOTHER
26 Previous Clinical Trials
94,621 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am not fluent in spoken English.I do not have significant cognitive impairment.I am unable or unwilling to give verbal consent.I am 65 years old or older.
Research Study Groups:
This trial has the following groups:- Group 1: eSTEPS Clinical Decision Support
- Group 2: Usual Care
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger